Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

SAFER Karachi - Une intervention de prévention des chutes (SAFER)

8 novembre 2026 mis à jour par: Sonia Sameen, Aga Khan University

SAFER Karachi : Renforcement d'une intervention adaptée de prévention des chutes pour la résilience chez les personnes âgées - Une étude pilote à Karachi

The goal of this pilot study is to evaluate the feasibility, acceptability, and short-term effects of a culturally adapted and strengthened fall prevention program in older adults aged 60 years and above living in urban Karachi, Pakistan. The study aims to understand whether a structured, community-based intervention can improve mobility, confidence, and overall well-being while reducing the risk of falls.

The main questions it aims to answer are:

  1. Is the adapted and strengthened fall prevention program feasible and acceptable for older adults in Karachi?
  2. Does participation in the program improve mobility, balance, fall-related self-efficacy, and psychological distress among participants?

Participants will:

  1. Take part in a 7-week group-based fall prevention program that includes strength and balance exercises, home safety education, medication awareness, and behavioral strategies
  2. Receive a home visit in Week 8 for endline assessment and evaluation of home-based adaptation and adherence
  3. Attend a booster session after 3 months to support continued engagement
  4. Complete assessments at baseline and at Week 8 (endline), including mobility, cognitive function, quality of life, and psychological distress
  5. Receive telephone follow-up calls for up to 6 months after the intervention to monitor adherence to recommended practices

Aperçu de l'étude

Description détaillée

Falls are a major public health concern among older adults and are a leading cause of injury, disability, and loss of independence worldwide. The burden is particularly high in low- and middle-income countries (LMICs), where over 80% of fall-related deaths occur. In Pakistan, and especially in urban settings like Karachi, older adults face compounded risks due to limited access to geriatric care, inadequate home safety infrastructure, financial constraints, and reliance on informal caregiving systems. Despite this growing burden, fall prevention remains underexplored and under-implemented in the local context.

Most evidence-based fall prevention interventions have been developed and tested in high-income countries, raising concerns about their applicability in LMIC settings due to differences in environmental conditions, health system structures, cultural norms, and resource availability. There is a critical need to adapt and evaluate such interventions to ensure they are feasible, acceptable, and effective within the local context.

The SAFER Karachi study (Strengthening an Adapted Fall Prevention Intervention for Resilience in Older Adults) is a pilot quasi-experimental study designed to address this gap. The study aims to adapt, strengthen, and evaluate a culturally relevant fall prevention intervention for community-dwelling older adults aged 60 years and above in urban Karachi.

The intervention is based on the evidence-based Stepping On program, a multi-component fall prevention strategy that integrates strength and balance training, environmental safety education, medication awareness, and behavioural change approaches to improve self-efficacy and reduce fall risk. While the core structure of the program will be retained, context-specific adaptations and strengthening measures will be incorporated to enhance feasibility, safety, and relevance in a low-resource urban setting. These include standardized facilitator training, physiotherapist-informed delivery of exercise components, integration of supportive tools to improve adherence, and minor refinements informed by formative research and local implementation considerations.

The study will use a pre-test and post-test quasi-experimental design and will enroll approximately 75 older adults from selected urban communities in Karachi. The intervention will be delivered over a 7-week period through structured group sessions led by trained facilitators. Each session will focus on key components of fall prevention, including physical exercises, home hazard identification, medication-related risk awareness, vision and footwear considerations, and behavioral strategies to support long-term adherence. Peer interaction and social support will be emphasized to enhance engagement and sustainability.

Following the weekly group sessions, participants will receive a home visit in Week 8 for endline assessment and evaluation of home-based adaptation and adherence, followed by a booster session at 3 months post-intervention to support continued engagement. Telephone follow-ups will continue for up to 6 months post-intervention to monitor adherence to recommended practices.

The primary focus of this pilot study is to assess the feasibility and acceptability of implementing the adapted intervention in Karachi's urban community settings. Feasibility will be evaluated through indicators such as recruitment rates, retention, session attendance, and adherence to intervention components. Acceptability will be assessed through participant feedback collected in focus group discussions and facilitator evaluations, providing insights into user experience and implementation challenges.

In addition, the study will assess short-term changes in selected health and functional outcomes at baseline and endline (Week 8), including mobility and balance, fall-related self-efficacy, cognitive function, psychological distress, nutritional status, sleep quality, activities of daily living, quality of life, and adherence to home and community safety modifications. Falls will be recorded by self-report, providing preliminary data to inform future research, although the study is not powered to detect long-term reductions in fall incidence.

Data collection will include baseline and endline assessments using standardized and validated tools, as well as qualitative interviews during the formative phase and focus group discussions after the intervention to explore participant experiences, barriers, facilitators, and recommendations for improvement. These findings will be used to further refine the intervention and enhance its contextual fit.

This pilot study is designed to generate critical preliminary evidence to inform a larger, fully powered trial. By identifying key implementation challenges, participant engagement patterns, and early outcome trends, the study will contribute to the development of a scalable, culturally appropriate fall prevention model for Pakistan and similar LMIC settings.

Ultimately, the SAFER Karachi study seeks to shift the focus from reactive management of fall-related injuries to proactive, community-based prevention strategies. By improving mobility, confidence, and overall well-being among older adults, this intervention has the potential to enhance independence and quality of life while reducing the burden on families and health systems.

Type d'étude

Interventionnel

Inscription (Réel)

75

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Sindh
      • Karachi, Sindh, Pakistan, 74800
        • Aga Khan University

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

60 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Older adults, aged 60 years and above, residing in urban Karachi
  • Able to ambulate independently, with or without a walking stick

Exclusion Criteria:

  • Individuals who are unable to stand independently, or requiring mobility assistive devices other than a walking stick
  • Individuals who are bedbound or homebound and require full-time assistance
  • Individuals with diagnosed cognitive impairment or dementia

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Autre
  • Répartition: N / A
  • Modèle interventionnel: Affectation à un seul groupe
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Intervention Arm

Participants will receive a 7-week group-based fall prevention intervention adapted for the local context. The program focuses on improving strength, balance, and safety awareness among older adults, with additional follow-up through a home visit and booster session to support sustained behaviour change.

This intervention is a culturally adapted and contextually strengthened version of the evidence-based Stepping On fall prevention program, tailored for older adults in a low-resource urban setting. Unlike standard implementations, this version incorporates context-specific modifications based on local environmental, social, and health system realities in Karachi.

Key distinguishing features include structured facilitator training to ensure standardized delivery, physiotherapist-informed guidance for exercise components to enhance safety, and integration of supportive tools to improve participant adherence and engagement. The intervention also includes follow-up reinforcement through home visits and a booster session to support sustained behaviour change.

These adaptations are designed to improve feasibility, acceptability, and scalability of the intervention within resource-constrained settings while retaining the core evidence-based components of the original program.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Feasibility of the Adapted Fall Prevention Intervention: Recruitment Rate
Délai: During enrollment, before the intervention starts

Proportion of eligible participants enrolled in the study. Expressed as a percentage (0-100%), with higher values indicating better feasibility.

During enrollment, before the intervention starts
Feasibility of the Adapted Fall Prevention Intervention: Retention Rate
Délai: From enrolment to endline assessment (Week 8)

Proportion of enrolled participants who complete the study. Expressed as a percentage (0-100%), with higher values indicating better feasibility.

From enrolment to endline assessment (Week 8)
Feasibility of the Adapted Fall Prevention Intervention: Session Attendance
Délai: From baseline to the end of the intervention (Weeks 1-7)

Number or proportion of intervention sessions attended by participants. Reported as a percentage or count, with higher values indicating better adherence.

From baseline to the end of the intervention (Weeks 1-7)
Feasibility of the Adapted Fall Prevention Intervention: Adherence to Intervention
Délai: From Week 1 to 6 months post-intervention

Extent to which participants follow prescribed intervention components. Reported as a proportion or score, with higher values indicating better adherence.

From Week 1 to 6 months post-intervention
Acceptability of the Adapted Fall Prevention Intervention: Acceptability Score
Délai: From baseline to the booster session, 3 months post-intervention

Measured using a Likert-scale questionnaire (e.g., 1-5), where higher scores indicate greater acceptability of the intervention.

From baseline to the booster session, 3 months post-intervention
Acceptability of the Adapted Fall Prevention Intervention: Participant Experience (Qualitative)
Délai: At the end of the intervention and follow-up (up to 1 month)

Assessed through qualitative interviews exploring participant experiences and perceptions of the intervention. Data will be analyzed thematically.

At the end of the intervention and follow-up (up to 1 month)
Acceptability of the Adapted Fall Prevention Intervention: Facilitator Evaluation
Délai: Weeks 1-7 (end of each session and end of the intervention)

Facilitator-reported acceptability will be assessed using a structured questionnaire adapted from the Acceptability of Intervention Measure (AIM), a validated 4-item scale evaluating appropriateness, satisfaction, appeal, and willingness to continue. Items are rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree). A mean score (range: 1-5) will be calculated, with higher scores indicating greater acceptability.

In addition, facilitators will complete a Structured Intervention Delivery Assessment Checklist covering ease of delivery, fidelity, and participant engagement. Items will be rated on a 5-point Likert scale (1 = poor/not at all to 5 = excellent/to a great extent). Mean domain and overall scores (range: 1-5) will be calculated, with higher scores indicating better implementation. Responses will be summarized descriptively.

Weeks 1-7 (end of each session and end of the intervention)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Short-term Functional and Psychosocial Outcomes: Activities of Daily Living (ADL)
Délai: Baseline (Week 0) and endline (Week 8)

Assessed using the Katz Index of Independence in Activities of Daily Living. Scores range from 0 to 6, with higher scores indicating greater independence.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Fall-Related Self-Efficacy
Délai: Baseline (Week 0) and endline (Week 8)

Measured using the Short Falls Efficacy Scale-International (Short FES-I). Scores range from 0 to 10 (or tool-specific range), with higher scores indicating greater confidence in performing activities without falling.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Mobility and Balance
Délai: Baseline (Week 0) and endline (Week 8)

Assessed using the Timed Up and Go (TUG) test. Performance is measured in seconds, with shorter times indicating better mobility and balance.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Nutritional Status
Délai: Baseline (Week 0) and endline (Week 8)

Measured using the Mini Nutritional Assessment-Short Form (MNA-SF). Scores range from 0 to 30, with higher scores indicating better nutritional status.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Sleep Quality
Délai: Baseline (Week 0) and endline (Week 8)

Assessed using the Pittsburgh Sleep Quality Index-Short (PSQI-Short). Scores range from 0 to 21, with higher scores indicating poorer sleep quality.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Quality of Life
Délai: Baseline (Week 0) and endline (Week 8)

Measured using the Older People's Quality of Life Questionnaire (OPQOL). Domain scores range from 0 to 100, with higher scores indicating better quality of life.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Cognitive Function
Délai: Baseline (Week 0) and endline (Week 8)

Assessed using the Mini Montreal Cognitive Assessment (Mini MoCA). Scores range from 0 to 30, with higher scores indicating better cognitive function.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Psychological Distress
Délai: Baseline (Week 0) and endline (Week 8)

Measured using the Kessler Psychological Distress Scale (K10). Scores range from 10 to 50, with higher scores indicating greater psychological distress.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Adherence to Safety Modifications
Délai: Baseline (Week 0) and endline (Week 8)

Adherence to recommended home and community safety modifications will be assessed using a structured Self-Reported Safety Modification Adherence Checklist developed for this study based on standard fall prevention guidelines from multiple sources, including the Otago guidelines, WHO, and more. The checklist will include multiple items covering home environment modifications, use of assistive devices, and safe mobility practices. Each item will be scored as 0 (not implemented), 1 (partially implemented), or 2 (fully implemented).

A total adherence score will be calculated by summing item responses, with scores ranging from 0 to the maximum possible based on applicable items; higher scores indicate greater adherence. Adherence may also be expressed as a proportion (%) of recommended modifications implemented.

Baseline (Week 0) and endline (Week 8)

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
Fall Incidence
Délai: Baseline, Week 8 (endline), booster session (3 months post-intervention), and up to 6 months post-intervention

Number of self-reported falls (ProFaNE consensus definition of falls)

Baseline, Week 8 (endline), booster session (3 months post-intervention), and up to 6 months post-intervention

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Sonia Sameen, MSc., Aga Khan University

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 septembre 2025

Achèvement primaire (Réel)

30 juin 2026

Achèvement de l'étude (Réel)

31 août 2026

Dates d'inscription aux études

Première soumission

19 mars 2026

Première soumission répondant aux critères de contrôle qualité

27 mars 2026

Première publication (Réel)

31 mars 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

12 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

8 novembre 2026

Dernière vérification

1 octobre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 2025-11554-35416
  • D43TW007292 (Subvention/contrat des NIH des États-Unis)
  • 2025 (Subvention/contrat des NIH des États-Unis)

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

De-identified individual participant data (IPD) underlying the results reported in this study will be made available to qualified researchers upon reasonable request. Data will be shared after publication of the primary study results and will include variables necessary to reproduce the findings.

All data sharing will be subject to approval by the principal investigator and the Aga Khan University Ethics Review Committee, and will require a data sharing agreement to ensure confidentiality, ethical use, and compliance with institutional policies.

Délai de partage IPD

Data will be available beginning 6 months after publication of the primary results and will remain available for up to 3 years.

Critères d'accès au partage IPD

Access will be granted to researchers with a methodologically sound proposal. Requests should be directed to the principal investigator and will be reviewed based on scientific merit, ethical considerations, and feasibility.

Type d'informations de prise en charge du partage d'IPD

  • PROTOCOLE D'ÉTUDE
  • SÈVE

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner